Neoadjuvant Therapy in Lung Cancer: What Is Most Important: Objective Response Rate or Major Pathological Response?

Lung cancer is the most fatal and frequently diagnosed malignant tumor. Neoadjuvant therapy is a promising approach for prolonging survival and increasing the chance of cure rates for patients with potentially resectable disease. Currently, many therapeutic alternatives, including chemotherapy, targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xi, Ma, Kewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535119/
https://www.ncbi.nlm.nih.gov/pubmed/34677268
http://dx.doi.org/10.3390/curroncol28050350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535119/
https://www.ncbi.nlm.nih.gov/pubmed/34677268
http://dx.doi.org/10.3390/curroncol28050350

Ejemplares similares